|
The Truth About Getting Sick in America: The Real Problems with Health Care and What We Can Do by Dr. Tim Johnson, reviewed by R. Sanderson
With a thirty year history as ABC's chief medical editor and senior medical contributor, member of the faculty at Harvard Medical School, and former staff member of Massachusetts General Hospital, Dr. Tim Johnson takes a candid look into the problems and proposals affecting health care.
New CME course on ME/CFS
Chronic Fatigue Syndrome: The Challenges in Primary Care, a new online Continuing Medical Education (CME) course, was published by Medscape and the Centers for Disease Control on March 23, 2012. Learn more about the course.
Advocacy Alert - Call for Action FDA Stakeholder Meeting - Deadline is May 2, please act now!
As patients and loved ones, we have suffered too long with too little research, a disbelieving medical community, and no approved drug treatment specifically for ME/CFS. This has to change!...We are calling on the FDA to hold a Stakeholder meeting to discuss approval of ME/CFS treatments. We need the FDA to hear from as many people as possible to ensure that the Stakeholder meeting happens.
President's Letter - Spring 2012
Love and Fatigue in America by Roger King, reviewed by Jean Zimmer
An account of being sick could be a hard sell in today’s book market. If the daily news itself can be a downer, why read a narrative about illness and disability?
Answer: Because fate is fickle. The book’s publication follows closely on the U.S. Supreme Court’s review of President Obama’s healthcare law. King’s well-crafted book raises important questions about how our society treats sick people. What happened to the narrator could happen to anyone. Perhaps the book could help inspire a remedy for a healthcare system that doesn’t seem very caring.
Reporting of Harms Associated with Graded Exercise Therapy and Cognitive Behavioural Therapy in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, by Tom Kindlon - This paper reports on the harms often experienced by ME/CFS patients as a result of these therapies, identifies problems with the reporting of harms in previous randomized controlled trials and suggests potential strategies for improvement in the future.
For Health Care Providers – New items have been added to the For Health Care Providers page:
|